P.D. Feldman

562 total citations
24 papers, 456 citations indexed

About

P.D. Feldman is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Clinical Psychology. According to data from OpenAlex, P.D. Feldman has authored 24 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 6 papers in Cellular and Molecular Neuroscience and 4 papers in Clinical Psychology. Recurrent topics in P.D. Feldman's work include Neuroscience of respiration and sleep (4 papers), Attention Deficit Hyperactivity Disorder (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). P.D. Feldman is often cited by papers focused on Neuroscience of respiration and sleep (4 papers), Attention Deficit Hyperactivity Disorder (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). P.D. Feldman collaborates with scholars based in United States. P.D. Feldman's co-authors include Richard J. Miller, Fletcher A. White, Robert B. Felder, Venkat K. Rao, David G. Dibbell, F.R. Sallee, Leon Dure, Denái R. Milton, Steven L. Linder and Donald W. Lewis and has published in prestigious journals such as Circulation, Neurology and Biological Psychiatry.

In The Last Decade

P.D. Feldman

24 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P.D. Feldman United States	12	174	111	101	98	82	24	456
Ivanor Meira‐Lima Brazil	9	182 1.0×	139 1.3×	74 0.7×	95 1.0×	17 0.2×	13	432
P Reich United States	11	51 0.3×	61 0.5×	103 1.0×	30 0.3×	54 0.7×	20	402
Jo Ann V. Antenor‐Dorsey United States	11	33 0.2×	155 1.4×	66 0.7×	79 0.8×	46 0.6×	16	564
R. Kerwin United Kingdom	9	167 1.0×	240 2.2×	44 0.4×	27 0.3×	14 0.2×	20	486
M. Barbanoj Spain	11	32 0.2×	97 0.9×	224 2.2×	43 0.4×	24 0.3×	24	451
A. Di Lieto Italy	12	25 0.1×	186 1.7×	41 0.4×	73 0.7×	72 0.9×	32	551
Andrej Tillinger Slovakia	12	84 0.5×	158 1.4×	25 0.2×	17 0.2×	50 0.6×	48	610
Heinrich Sauer Germany	11	105 0.6×	37 0.3×	102 1.0×	33 0.3×	13 0.2×	43	549
Takeshi Inoue Japan	9	86 0.5×	144 1.3×	129 1.3×	48 0.5×	16 0.2×	30	432
David O. Keyser United States	11	57 0.3×	163 1.5×	128 1.3×	26 0.3×	22 0.3×	20	473

Countries citing papers authored by P.D. Feldman

Since Specialization

Citations

This map shows the geographic impact of P.D. Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.D. Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.D. Feldman more than expected).

Fields of papers citing papers by P.D. Feldman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.D. Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.D. Feldman. The network helps show where P.D. Feldman may publish in the future.

Co-authorship network of co-authors of P.D. Feldman

This figure shows the co-authorship network connecting the top 25 collaborators of P.D. Feldman. A scholar is included among the top collaborators of P.D. Feldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.D. Feldman. P.D. Feldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

White, Fletcher A., P.D. Feldman, & Richard J. Miller. (2009). Chemokine Signaling and the Management of Neuropathic Pain. Molecular Interventions. 9(4). 188–195. 72 indexed citations

Newcorn, Jeffrey H., et al.. (2006). EFFECTS OF LONGER-TERM ATOMOXETINE TREATMENT IN ADOLESCENTS WITH ADHD. Neuropediatrics. 37(S 1). 1 indexed citations

Allen, A.J., Roger Kurlan, Donald L. Gilbert, et al.. (2005). Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology. 65(12). 1941–1949. 155 indexed citations

Meehan, Karena, et al.. (2001). Intramuscular olanzapine: Efficacy and safety in acutely agitated patients with dementia. European Neuropsychopharmacology. 11. S323–S323. 1 indexed citations

Sutton, Virginia K., J. Street, John Kennedy, P.D. Feldman, & Alan Breier. (2001). Superiority of olanzapine over risperidone in the control of negative symptoms of schizophrenia and related psychotic disorders in older patients. European Neuropsychopharmacology. 11. S276–S276. 8 indexed citations

Street, J., et al.. (2000). Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in patients with Alzheimer's dementia. European Neuropsychopharmacology. 10. 365–366. 2 indexed citations

Street, J., et al.. (2000). P01.100 Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in patients with alzheimer's dementia. European Psychiatry. 15(S2). 346s–347s. 1 indexed citations

Clark, W. Scott, J. Street, T.M. Sanger, P.D. Feldman, & Alan Breier. (2000). 534. Reduction of psychotic symptoms in patients with Lewy body-like symptoms treated with olanzapine. Biological Psychiatry. 47(8). S163–S163. 1 indexed citations

Tohen, Mauricio, T. Jacobs, P.D. Feldman, et al.. (2000). 275. Is olanzapine a mood-stabilizer?. Biological Psychiatry. 47(8). S83–S83. 3 indexed citations

10.

Street, J., et al.. (2000). 532. Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in patients with Alzheimer’s dementia. Biological Psychiatry. 47(8). S162–S162. 3 indexed citations

11.

Frazier, Jean A., Mauricio Tohen, Joseph Biederman, et al.. (2000). Olanzapine in the treatment of juvenile bipolar disorder. European Neuropsychopharmacology. 10. 247–247. 3 indexed citations

12.

Frazier, Jean A., Joseph Biederman, T. Jacobs, et al.. (2000). Olanzapine in the treatment of bipolar-disorder in juveniles. Schizophrenia Research. 41(1). 194–194. 11 indexed citations

13.

Feldman, P.D. & Floyd Galiano. (1995). Cardiovascular effects of serotonin in the nucleus of the solitary tract. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 269(1). R48–R56. 13 indexed citations

14.

Feldman, P.D.. (1995). Neurokinin1 receptor mediation of the vasodepressor effects of substance P in the nucleus of the tractus solitarius.. Journal of Pharmacology and Experimental Therapeutics. 273(2). 617–623. 38 indexed citations

15.

Feldman, P.D. & Robert B. Felder. (1991). Effects of γ-aminobutyric acid and glycine on synaptic excitability of neurones in the solitary tract nucleus. Neuropharmacology. 30(3). 225–236. 23 indexed citations

16.

Feldman, P.D. & Robert B. Felder. (1989). α-Adrenergic influences on neuronal responses to visceral afferent input in the nucleus tractus solitarius. Neuropharmacology. 28(10). 1081–1087. 20 indexed citations

17.

Rao, Venkat K., P.D. Feldman, & David G. Dibbell. (1988). Extravasation injury to the hand by intravenous phenytoin. Journal of neurosurgery. 68(6). 967–969. 33 indexed citations

18.

Feldman, P.D. & Hylan C. Moises. (1988). Electrophysiological evidence for alpha 1- and alpha 2-adrenoceptors in solitary tract nucleus. American Journal of Physiology-Heart and Circulatory Physiology. 254(4). H756–H762. 18 indexed citations

19.

Feldman, P.D.. (1985). Fault tolerance of minimal path routings in a network. 327–334. 13 indexed citations

20.

Wetstein, Lewis, et al.. (1982). Mediation of cardiac ischemia by thromboxanes released from human platelets.. PubMed. 92(2). 292–8. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact